Oxford BioDynamics (LSE:OBD) ROE % Adjusted to Book Value: -64.58% (As of Sep. 2025)


What is Oxford BioDynamics ROE % Adjusted to Book Value?

Oxford BioDynamics LSE:OBD -5.00% ROE % Adjusted to Book Value is -64.58% as of Sep. 2025. The stock has 4 warning signs investors should review.

Oxford BioDynamics's ROE % for the quarter that ended in Sep. 2025 was -306.76%. Oxford BioDynamics's PB Ratio for the quarter that ended in Sep. 2025 was 4.75. Oxford BioDynamics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 was -64.58%.

Oxford BioDynamics ROE % Adjusted to Book Value Related Terms

Oxford BioDynamics ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Oxford BioDynamics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford BioDynamics ROE % Adjusted to Book Value Chart

Oxford BioDynamics Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.97 -32.77 -20.32 -96.59 -85.79

Oxford BioDynamics Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.22 -20.95 -198.98 -141.54 -64.58

LSE:OBD vs TMO, DHR, IDXX: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Oxford BioDynamics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oxford BioDynamics ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Oxford BioDynamics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's ROE % Adjusted to Book Value falls into.


Oxford BioDynamics ROE % Adjusted to Book Value Calculation

Oxford BioDynamics's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-407.49% / 4.75
=-85.79%

Oxford BioDynamics's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-306.76% / 4.75
=-64.58%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -64.58% mean?
Oxford BioDynamics (LSE:OBD) has a ROE % Adjusted to Book Value of -64.58% as of Sep. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Oxford BioDynamics and its competitors.
Is Oxford BioDynamics' ROE % Adjusted to Book Value too high?
Oxford BioDynamics' current ROE % Adjusted to Book Value is -64.58%.
How does Oxford BioDynamics' ROE % Adjusted to Book Value compare to TMO and DHR?
Oxford BioDynamics' ROE % Adjusted to Book Value of -64.58% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Oxford BioDynamics and its competitors. Oxford BioDynamics's current ROE % Adjusted to Book Value is -64.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford BioDynamics stock overvalued right now?
Based on GuruFocus' analysis, Oxford BioDynamics (LSE:OBD) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.00 — trading 95.3% below its estimated fair value. The current ROE % Adjusted to Book Value is -64.58%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Oxford BioDynamics (LSE:OBD), the current ROE % Adjusted to Book Value is -64.58% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oxford BioDynamics Business Description

Other Exchanges OXBOF:USALMQ:Germany
Address John Smith Drive, 3140 Rowan Place, Oxford Business Park South, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company focused on advancing personalized healthcare through the development and commercialization of precision medicine tests for serious and impactful diseases. The company is engaged in the commercialisation of proprietary molecular diagnostics products and biomarker research and development. It has two commercially available products: the EpiSwitch PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch CiRT (Checkpoint Inhibitor Response Test) blood tests. The company generates revenue from the sales of proprietary products and biomarker research and development. Geographically, it generates the maximum revenue from the USA.